KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Other Working Capital Changes (2017 - 2025)

Amneal Pharmaceuticals has reported Other Working Capital Changes over the past 9 years, most recently at -$1.0 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$1.0 million for Q4 2025, up 10.06% from a year ago — trailing twelve months through Dec 2025 was $19.2 million (up 1898.23% YoY), and the annual figure for FY2025 was $19.2 million, up 1898.23%.
  • Other Working Capital Changes for Q4 2025 was -$1.0 million at Amneal Pharmaceuticals, down from $10.2 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for AMRX hit a ceiling of $115.3 million in Q2 2022 and a floor of -$85.4 million in Q3 2022.
  • Median Other Working Capital Changes over the past 5 years was -$806000.0 (2021), compared with a mean of -$279650.0.
  • Peak annual rise in Other Working Capital Changes hit 834.72% in 2022, while the deepest fall reached 2535.58% in 2022.
  • Amneal Pharmaceuticals' Other Working Capital Changes stood at -$5.5 million in 2021, then tumbled by 703.01% to -$44.3 million in 2022, then surged by 70.62% to -$13.0 million in 2023, then surged by 91.36% to -$1.1 million in 2024, then increased by 10.06% to -$1.0 million in 2025.
  • The last three reported values for Other Working Capital Changes were -$1.0 million (Q4 2025), $10.2 million (Q3 2025), and $9.5 million (Q2 2025) per Business Quant data.